Markets & Regulations

(RUNSTUDIO/iStock via Getty Images Plus)

CPHI NORTH AMERICA 2021

M&A activity vigorous in CDMO arena: CPhI

By Jenni Spinner

An expert speaking during the industry event offers insight and perspective on the flurry of CDMO deal-making in recent months, and what might lie ahead.

© GettyImages/janiecbros

EU go-ahead for bluebird bio gene therapy for CALD

By Jane Byrne

Bluebird’s Lenti-D, or elivaldogene autotemcel, has won approval from the European Commission to treat children with a rare neurodegenerative disease called early cerebral adrenoleukodystrophy (CALD).

© GettyImages/FlashMovie

NPD Gallery: Technology Insider

By Jane Byrne

We report on some of the latest biopharma industry targeted new releases in terms of technological innovation.

Follow us

Products

View more

Webinars